Application of dual phase imaging of11C-acetate positron emission tomography on differential diagnosis of small hepatic lesions

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Huo, Li ^a   Dang, Yonghong ^a   Lv, Jingqiao ^a   Xing, Haiqun ^a   Li, Fang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; ACETIC ACID DERIVATIVE; CARBON; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER HISTOLOGY; LIVER TUMOR; MALE; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; AGED; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING;

ACETATES; ADULT; AGED; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84901228023     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096517     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
2. Jarnagin WR (2010) Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol 17: 1226-1233.
3. Ho CL, Yu SC, Yeung DW (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44: 213-221.
4. Larsson P, Arvidsson D, Bjornstedt M, Isaksson B, Jersenius U, et al. (2012) Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma. Mol Imaging Radionucl Ther 21: 6-12.
5. Hwang KH, Choi DJ, Lee SY, Lee MK, Choe W (2009) Evaluation of patients with hepatocellular carcinomas using [(11)C]acetate and [(18)F]FDG PET/CT: A preliminary study. Appl Radiat Isot 67: 1195-1198.
6. Park JW, Kim JH, Kim SK, Kang KW, Park KW, et al. (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49: 1912-1921.
7. Salem N, Kuang Y, Wang F, Maclennan GT, Lee Z (2009) PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline. Q J Nucl Med Mol Imaging 53: 144-156.
8. Shiomi S, Kurooka H, Iwata Y, Sasaki N, Masaki K, et al. (1999) Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG. Ann Nucl Med 13: 427-431. (Pubitemid 30073614)
9. Kurtaran A, Becherer A, Pfeffel F, Muller C, Traub T, et al. (2000) 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. Liver 20: 487-490. (Pubitemid 32000742)
10. Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, et al. (2009) C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med 34: 659-665.
11. Lecler A, Arrive L (2011) Focal nodular hyperplasia. Clin Res Hepatol Gastroenterol 35: 159-160.
12. Huo L, Wu Z, Zhuang H, Fu Z, Dang Y (2009) Dual time point C-11 acetate PET imaging can potentially distinguish focal nodular hyperplasia from primary hepatocellular carcinoma. Clin Nucl Med 34: 874-877.
13. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503.
14. Mitterhauser M, Wadsak W, Krcal A, Schmaljohann J, Bartosch E, et al. (2004) New aspects on the preparation of [11C]acetate-a simple and fast approach via distillation. Appl Radiat Isot 61: 1147-1150. (Pubitemid 39248930)
15. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22: 1674-1681.
16. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J (2006) Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 16: 1873-1886. (Pubitemid 44193172)
17. Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219: 699-706. (Pubitemid 32476260)
18. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, et al. (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20: 379-397.
19. Chen S, Ho C, Feng D, Chi Z (2004) Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography. IEEE Trans Med Imaging 23: 426-432.
20. Yang ZF, Poon RT (2008) Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken) 291: 721-734.
21. Byam J, Renz J, Millis J (2013) Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition 2: 9.
22. Yamamoto T, Hirohashi K, Kaneda K, Ikebe T, Mikami S, et al. (2001) Relationship of the microvascular type to the tumor size, arterialization and dedifferentiation of human hepatocellular carcinoma. Jpn J Cancer Res 92: 1207-1213. (Pubitemid 33133490)
23. Yoshii Y, Waki A, Furukawa T, Kiyono Y, Mori T, et al. (2009) Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. Nucl Med Biol 36: 771-777.